Cargando…
Rare Case of Olmesartan Induced Enteropathy
Olmesartan (brand name Benicar) is an antihypertensive drug clinicians commonly use to treat high blood pressure. Olmesartan induced enteropathy (OSE) is a rare entity that authors first identified in 2012. The etiological basis of OSE remains unclear, although authors have suggested that this condi...
Autores principales: | Handa, Richa, Rahman, Akhil, Kak, Vivek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MSU College of Osteopathic Medicine Statewide Campus System
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7746095/ https://www.ncbi.nlm.nih.gov/pubmed/33655123 http://dx.doi.org/10.51894/001c.6383 |
Ejemplares similares
-
Olmesartan‐induced enteropathy associated with cutaneous lesions
por: Hammoudi, Nassim, et al.
Publicado: (2016) -
Enteropathy Associated with Olmesartan
por: Silva, Bruno Moreira da, et al.
Publicado: (2015) -
Olmesartan-Induced Sprue Like Enteropathy
por: Carneiro, Liliana, et al.
Publicado: (2016) -
Olmesartan-induced Enteropathy Manifesting as Wernicke-Korsakoff Syndrome
por: Uehara, Takanori, et al.
Publicado: (2016) -
Olmesartan-medoxomil: Sprue-like enteropathy: case report
Publicado: (2021)